Overview
Hiroaki Kodama practices in Shimonagakubo, Japan. Mr. Kodama is highly rated in 3 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
His clinical research consists of co-authoring 94 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerMr. Kodama isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)Mr. Kodama isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Acute Interstitial PneumoniaMr. Kodama isExperienced. Learn about Acute Interstitial Pneumonia.
- EGFR Positive Lung CancerMr. Kodama isExperienced. Learn about EGFR Positive Lung Cancer.
- Embryonal Tumor with Multilayered Rosettes
- Febrile NeutropeniaMr. Kodama isExperienced. Learn about Febrile Neutropenia.
- Gliomatosis CerebriMr. Kodama isExperienced. Learn about Gliomatosis Cerebri.
- Interstitial Lung DiseaseMr. Kodama isExperienced. Learn about Interstitial Lung Disease.